Sunmin Lee

12PUBLICATIONS
102CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Electrochemical energy storage and conversionMolecular targetsSequence analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 22, 2026
Blockade of Tumor-Intrinsic TGFβ Signaling Drives Hyperprogression in Small Cell Lung Cancer.

|Mar 17, 2026
Durvalumab and cediranib with and without olaparib in recurrent ovarian cancer: a phase II proof-of-concept study.

Junya Tabata, Tzu-Ting Huang, Elena Giudice

|Nov 19, 2025
Phase II proof-of-concept study of durvalumab and cediranib with and without olaparib in recurrent ovarian cancer.

Jung-Min Lee, Junya Tabata, Tzu-Ting Huang

|May 16, 2025
Mitochondrial HSP90 Paralog TRAP1 Deletion Drives Glutamine Addiction in Tumor Cells via Destablization of the Cys/Glu Antiporter SLC7A11/xCT.

Abhinav Joshi, Li Dai, Marisa Maisiak

|May 25, 2023
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.

Melissa L Abel, Nobuyuki Takahashi, Cody Peer

|Jan 15, 2022
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy.

Daniel M Girardi, Scot A Niglio, Amir Mortazavi

Pageof 2

Frequent Collaborators

3 joint publications

Shraddha Rastogi

3 joint publications

Nahoko Sato

3 joint publications

Bernadette Redd

2 joint publications

Bill H Chang